The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Bristol-Myers Squibb Co

NYSE: BMY
Last

(U.S.) $61.85

Today's change+1.93 +3.22%
Updated January 17 4:00 PM EST. Delayed by at least 15 minutes.
 

Bristol-Myers Squibb Co

NYSE: BMY
Last

(U.S.) $61.85

Today's change+1.93 +3.22%
Updated January 17 4:00 PM EST. Delayed by at least 15 minutes.

Bristol-Myers Squibb Co crosses above 125-day moving average

Bristol-Myers Squibb Co closed up sharply Wednesday, rallying (U.S.)$1.93 or 3.22% to (U.S.)$61.85 and crossing above its 125-day moving average. Shares have lost 0.26% for the last five days, but have gained 9.90% over the last 52 weeks. This security has underperformed the S&P 500 by 13.68% during the last year.

Key company metrics

  • Open(U.S.) $60.33
  • Previous close(U.S.) $59.92
  • High(U.S.) $62.00
  • Low(U.S.) $60.28
  • Bid / Ask-- / --
  • YTD % change+0.93%
  • Volume10,608,482
  • Average volume (10-day)7,113,576
  • Average volume (1-month)5,776,725
  • Average volume (3-month)5,662,261
  • 52-week range(U.S.) $46.01 to (U.S.) $66.10
  • Beta1.07
  • Trailing P/E24.33×
  • P/E 1 year forward19.99×
  • Forward PEG1.87×
  • Indicated annual dividend(U.S.) $1.60
  • Dividend yield2.59%
  • Trailing EPS(U.S.) $2.54
Updated January 17 4:00 PM EST. Delayed by at least 15 minutes.
S&P TSX0.17%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201709/30/2017Jun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016
Revenue5,2545,1444,9295,243
Total other revenue--------
Total revenue5,2545,1444,9295,243
Gross profit3,6833,7123,6703,866
Total cost of revenue1,5711,4321,2591,377
Total operating expense4,0703,8092,9684,115
Selling / general / administrative1,1471,1671,0741,461
Research & development1,1691,1701,0911,387
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)392725-25730
Other operating expenses, total-209-685-199-140
Operating income1,1841,3351,9611,128
Interest income (expense), net non-operating-48-52-45-40
Gain (loss) on sale of assets--------
Other--------
Income before tax1,1831,2951,9551,086
Income after tax8569221,526898
Income tax, total327373429188
Net income8459161,574894
Total adjustments to net income--------
Net income before extra. items8459161,574894
Minority interest-11-648-4
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items8459161,574894
Inc. avail. to common incl. extra. items8459161,574894
Diluted net income8459161,574894
Dilution adjustment--------
Diluted weighted average shares1,6451,6501,6711,683
Diluted EPS excluding extraordinary itemsvalue per share0.510.560.940.53
Dividends per sharevalue per share0.390.390.390.38
Diluted normalized EPSvalue per share0.690.870.820.55